We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


PerkinElmer Launches Innovative Solaris™ Optical Imaging System

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

PerkinElmer Inc. has announced the launch of the Solaris™ quantitative optical molecular imaging system. This preclinical solution for use in small and large animal studies will help to advance drug discovery and translational research to develop and validate molecular-guided surgical research protocols.

The Solaris system, when combined with PerkinElmer’s suite of fluorescence molecular imaging probes, can bridge molecular imaging research techniques to support potential clinical outcomes. By distinguishing healthy versus diseased tissue in real-time, researchers can more accurately and completely map tumors.

“The Solaris system is our latest breakthrough translational quantitative imaging solution designed to facilitate disease studies and advance next-generation, molecular-level surgical support research,” said Brian Kim, President, Life Sciences & Technology, PerkinElmer. “Translational drug discovery validation in large animal models enhances toxicity and efficacy predictability in humans and provides critical knowledge for drug development programs.”

The Solaris system is designed for ambient lighting conditions found in preclinical surgical research suites and can dynamically use a broad and versatile range of fluorescent probes, offering flexibility for translational researchers when targeting diseases.

Its research applications include drug efficacy, drug safety, measurement of real-time biological therapeutic responses, and advanced molecular-guided surgery applications such as surgical tumor margin determination in live animal models.

PerkinElmer will showcase the Solaris system at the World Molecular Imaging Congress (WMIC) 2014 beginning September 17 in Seoul, South Korea. The company will also display the G8 bench-top PET/CT translational imaging system available through its collaboration with Sofie Biosciences, along with its new Quantum™ GX microCT in vivo imaging system and selected additional PerkinElmer optical in vivo imaging systems.